Delcath Systems - DCTH Operating profit EBITDA
Delcath Systems, Inc. (DCTH) is focusing on the independent market launch of its liver therapy system. The cash EBITDA figure confirms this stage, recording the metric at 0.00. However, geopolitical tensions and export restrictions could hinder global growth. Additional challenges include innovative treatment methods from industry behemoths, creating fierce competition within the high-tech oncology sector.
Delcath Systems (DCTH) - metric breakdowns and financial figures
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
DCTH - Net Income|Future Net Profit Delcath Systems, Inc.|DCTH - P/E Multiple|Future Price to Earnings Multiple delcath.com|DCTH - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Delcath Systems|DCTH - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Delcath Systems|DCTH - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months delcath.com|DCTH - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Delcath Systems, Inc.
Analysis of all company metrics:Delcath Corp (DCTH)
This indicator measures daily cash flow from core operations before interest and taxes, allowing for an assessment of operational resilience and the business's actual ability to generate cash. For Delcath Systems, Inc. (DCTH) with its asset-light model and outsourced production, the company's aggregate EBITDA demonstrates the efficiency of commercializing R&D solutions without the burden of capital expenditures for manufacturing plants.
Who Delcath Systems, Inc. competes with
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|erasca.com - Operating profit before amortization|Operating profit EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Aura Biosciences Inc (AURA) - Profit before interest, taxes and amortization|CADL - Profit before payment of interest, taxes and amortization|ARAY: Profit before payment of interest, taxes and amortization|SLS: Operating profit EBITDA|Operating profit before deduction of amortization actuatetherapeutics.com|CTOR (Citius Oncology) - Operating profit EBITDA|Operating profit EBITDA TuHURA|Operating profit before deduction of amortization TARA (Protara)|Company profit before taxes, interest and amortization FATE|Operating profit EBITDA WHWK (Aadi Bioscience)|Income before deduction of interest, taxes and amortization TCRX|CSBR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization XBIT (XBiotech Inc.)|cel-sci.com (CVM) - Profit before payment of interest, taxes and amortization|OSTX - Operating income before deduction of amortization|Operating profit before deduction of amortization RADX|Profit before interest, taxes and amortization Artiva ARTV|Profit before payment of interest, taxes and amortization Adlai Nortye Ltd. (ANL)|Operating income before deduction of amortization Veru Inc|Tempest Tx - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization XLO (Xilio Therapeutics Inc)|Enochian BioSciences - Operating profit EBITDA|Profit before interest, taxes and amortization Mural Oncology plc|kairospharma.com (KAPA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization OnKure Therapeutics|Profit before payment of interest, taxes and amortization CytoMed Therapeutics Ltd|Curis Corp (CRIS) - Operating income before deduction of amortization|Operating profit before deduction of amortization APLM (Apollomics, Inc.)|THAR (tharimmune.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ADVB (Advanced Biomed)|Operating income before deduction of amortization Genprex Inc. (GNPX)|CLDI - Profit before payment of interest, taxes and amortization|SBFM (sunshinebiopharma.com) - Operating profit before amortization|XBIO: Operating profit EBITDA|Operating profit before deduction of amortization salariuspharma.com|Operating profit before deduction of amortization PPBT|AON (AONC) - Operating income before deduction of amortization|Operating profit EBITDA BGNE|Checkpoint Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA ELEV (Elevation Oncology)|ICAD - Operating profit before deduction of amortization|IKNA: Operating profit before deduction of amortization|Notable Labs Ltd - Company profit before taxes, interest and amortization|VIRX: Operating profit EBITDA|MorphoSys Corporation - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
